series-a
Stage
1
Investors
About
Reccan develops a blood-based test for early detection of pancreatic cancer, aiming to enable earlier diagnosis and thereby improve treatment outcomes and quality of life.
Explore Reccan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.